Vault-13

Ikarian Capital, LLC

DALLAS, TX · CIK 1778253 · 13F filing filed 2020-01-31

SEC-registered investment adviser since 2020 · limited liability company

As an employer

$108.7m reported value
53positions
54.4%in top 10
—no comparable previous quarter

Options: 37 call positions ($212.7m notional), 24 put positions ($295.8m notional) – listed below, not included above.

Holdings, Q4 2019

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 AURINIA PHARMACEUTICALS INC COM AUPH AUPH 481,104 $9.7m8.97% 8.97% —
2 SAGE THERAPEUTICS INC COM SAGE SAGE 133,000 $9.6m8.83% 8.83% —
3 IMMUNOVANT INC COM IMVT IMVT 504,117 $8.0m7.36% 7.36% —
4 APTOSE BIOSCIENCES INC COM NEW COM NEW 1,009,735 $5.7m5.27% 5.27% —
5 CHIASMA INC COM CHMA CHMA 1,103,297 $5.5m5.03% 5.03% —
6 ARDELYX INC COM ARDX ARDX 645,436 $4.8m4.46% 4.46% —
7 OTONOMY INC COM OTIC OTIC 1,067,271 $4.1m3.76% 3.76% —
8 MADRIGAL PHARMACEUTICALS INC COM MDGL MDGL 44,770 $4.1m3.75% 3.75% —
9 KALVISTA PHARMACEUTICALS INC COM KALV KALV 212,420 $3.8m3.48% 3.48% —
10 KALA PHARMACEUTICALS INC COM COM 1,023,431 $3.8m3.47% 3.47% —
11 TG THERAPEUTICS INC COM TGTX TGTX 316,200 $3.5m3.23% 3.23% —
12 ASSEMBLY BIOSCIENCES INC COM COM 157,468 $3.2m2.96% 2.96% —
13 XENON PHARMACEUTICALS INC COM XENE XENE 243,470 $3.2m2.94% 2.94% —
14 ARQULE INC COM ARQL ARQL 148,930 $3.0m2.74% 2.74% —
15 CERECOR INC COM COM 519,800 $2.8m2.58% 2.58% —
16 PUMA BIOTECHNOLOGY INC COM PBYI PBYI 311,253 $2.7m2.51% 2.51% —
17 ANAPTYSBIO INC COM ANAB ANAB 143,000 $2.3m2.14% 2.14% —
18 BIOXCEL THERAPEUTICS INC COM COM 158,373 $2.3m2.13% 2.13% —
19 OCULAR THERAPEUTIX INC COM OCUL OCUL 557,659 $2.2m2.03% 2.03% —
20 ADURO BIOTECH INC COM ADRO ADRO 1,838,528 $2.2m2.00% 2.00% —
21 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 50,000 $2.1m1.97% 1.97% —
22 CHEMOCENTRYX INC COM CCXI CCXI 46,423 $1.8m1.69% 1.69% —
23 MALLINCKRODT PUB LTD CO SHS MNK MNK 512,000 $1.8m1.64% 1.64% —
24 OVID THERAPEUTICS INC COM OVID OVID 350,000 $1.5m1.34% 1.34% —
25 INFLARX NV COM IFRX IFRX 359,128 $1.4m1.31% 1.31% —
26 AIMMUNE THERAPEUTICS INC COM AIMT AIMT 40,000 $1.3m1.23% 1.23% —
27 MUSTANG BIO INC COM MBIO MBIO 323,235 $1.3m1.21% 1.21% —
28 PRECISION BIOSCIENCES INC COM COM 80,000 $1.1m1.02% 1.02% —
29 VIKING THERAPEUTICS INC COM VKTX VKTX 126,159 $1.0m0.93% 0.93% —
30 AXOVANT GENE THERAPIES LTD COM AXON AXON 188,884 $967.0k0.89% 0.89% —
31 APPLIED GENETIC TECHNOLOGIES COM AGTC AGTC 200,884 $908.0k0.84% 0.84% —
32 DBV TECHNOLOGIES S A SPONSORED ADR SPONSORED ADR 74,538 $798.0k0.73% 0.73% —
33 RIGEL PHARMACEUTICALS INC COM NEW COM NEW 350,000 $749.0k0.69% 0.69% —
34 MINERVA NEUROSCIENCES INC COM NERV NERV 100,000 $711.0k0.65% 0.65% —
35 PROGENICS PHARMACEUTICALS IN COM PGNX PGNX 130,845 $666.0k0.61% 0.61% —
36 BELLUS HEALTH INC NEW COM NEW BLU BLU 63,721 $625.0k0.58% 0.58% —
37 MOLECULAR TEMPLATES INC COM COM 40,907 $572.0k0.53% 0.53% —
38 PROTAGONIST THERAPEUTICS INC COM PTGX PTGX 78,326 $552.0k0.51% 0.51% —
39 PROTHENA CORP PLC SHS PRTA PRTA 29,832 $472.0k0.43% 0.43% —
40 CHIMERIX INC COM CMRX CMRX 172,920 $351.0k0.32% 0.32% —
41 OBSEVA SA COM COM 82,573 $315.0k0.29% 0.29% —
42 PROTEON THERAPEUTICS INC COM PRTO PRTO 336,373 $138.0k0.13% 0.13% —
43 SIERRA ONCOLOGY INC COM SRRA SRRA 386,399 $132.0k0.12% 0.12% —
44 MAGENTA THERAPEUTICS INC COM COM 8,674 $131.0k0.12% 0.12% —
45 STEALTH BIOTHERAPEUTICS CORP SPONSORED ADS SPONSORED ADS 37,597 $123.0k0.11% 0.11% —
46 MACROGENICS INC COM MGNX MGNX 10,030 $109.0k0.10% 0.10% —
47 AETERNA ZENTARIS INC COM COM 117,443 $107.0k0.10% 0.10% —
48 X4 PHARMACEUTICALS INC COM COM 10,000 $107.0k0.10% 0.10% —
49 NOVAVAX INC COM NEW NVAX NVAX 25,049 $100.0k0.09% 0.09% —
50 SUNESIS PHARMACEUTICALS INC COM SNSS SNSS 111,445 $38.0k0.03% 0.03% —
51 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 642 $35.0k0.03% 0.03% —
52 ALPINE IMMUNE SCIENCES INC COM NVLS NVLS 4,739 $18.0k0.02% 0.02% —
53 APELLIS PHARMACEUTICALS INC COM APLS APLS 53 $2.0k0.00% 0.00% —

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
INTERCEPT PHARMACEUTICALS IN ICPT · Put ICPTPut 754,900 $93.5m754.9k shares —
SPDR SER TR XBI · Put XBIPut 350,000 $33.3m350.0k shares —
GILEAD SCIENCES INC GILD · Call GILDCall 500,000 $32.5m500.0k shares —
INTRA-CELLULAR THERAPIES INC ITCI · Put ITCIPut 924,100 $31.7m924.1k shares —
ISHARES TR IBB · Put IBBPut 250,000 $30.1m250.0k shares —
ALLAKOS INC ALLKG · Call ALLKGCall 158,800 $15.1m158.8k shares —
SAREPTA THERAPEUTICS INC SRPT · Call SRPTCall 102,600 $13.2m102.6k shares —
MIRATI THERAPEUTICS INC MRTX · Call MRTXCall 100,000 $12.9m100.0k shares —
BEIGENE LTD ONC · Put ONCPut 77,000 $12.8m77.0k shares —
GOSSAMER BIO INC GOSS · Put GOSSPut 771,100 $12.1m771.1k shares —
BIOHAVEN PHARMACTL HLDG CO L BHVN · Call BHVNCall 200,000 $10.9m200.0k shares —
GW PHARMACEUTICALS PLC GWPH · Call GWPHCall 100,000 $10.5m100.0k shares —
ARQULE INC ARQL · Call ARQLCall 497,700 $9.9m497.7k shares —
ASCENDIS PHARMA A/S Call Call 69,400 $9.7m69.4k shares —
IMMUNOMEDICS INC IMMU · Call IMMUCall 448,200 $9.5m448.2k shares —
INTRA-CELLULAR THERAPIES INC ITCI · Call ITCICall 267,100 $9.2m267.1k shares —
MADRIGAL PHARMACEUTICALS INC MDGL · Put MDGLPut 100,000 $9.1m100.0k shares —
APELLIS PHARMACEUTICALS INC APLS · Put APLSPut 286,900 $8.8m286.9k shares —
INTERCEPT PHARMACEUTICALS IN ICPT · Call ICPTCall 64,900 $8.0m64.9k shares —
GLOBAL BLOOD THERAPEUTICS IN GBT · Call GBTCall 100,000 $7.9m100.0k shares —
ZOGENIX INC ZGNX · Put ZGNXPut 148,200 $7.7m148.2k shares —
CRISPR THERAPEUTICS AG CRSP · Put CRSPPut 123,700 $7.5m123.7k shares —
APELLIS PHARMACEUTICALS INC APLS · Call APLSCall 240,300 $7.4m240.3k shares —
INCYTE CORP INCY · Call INCYCall 80,000 $7.0m80.0k shares —
ARQULE INC ARQL · Put ARQLPut 336,400 $6.7m336.4k shares —

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
NEXTCURE INC NXTC · 13G · filed 2026-08-14 NXTC 10.0%≈ $804.3k no change 13G 2026-08-14
CNS PHARMACEUTICALS INC CNSP · 13G · filed 2026-08-14 CNSP 9.9%≈ $704.0k +4.2 pts 13G 2026-08-14
TRAWS PHARMA INC TRAW · 13G · filed 2026-08-14 TRAW 9.5%≈ $1.3m -0.5 pts 13G 2026-08-14
QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-08-14 IRLA 9.0%≈ $1.7m new 13G 2026-08-14
PELTHOS THERAPEUTICS INC PTHS · 13G · filed 2026-05-15 PTHS 7.7%≈ $7.3m -0.7 pts 13G 2026-05-15
CHANNEL THERAPEUTICS CORPORA 13G · filed 2025-02-14 7.3% new 13G 2025-02-14
CONNECT BIOPHARMA HLDGS LTD 13G · filed 2026-08-14 6.9% -1.9 pts 13G 2026-08-14
LIPOCINE INC NEW LPCN · 13G · filed 2026-05-15 LPCN 6.3% new 13G 2026-05-15